Experimental Treatment Could Be ‘Game-Changing’ for Genetic ALS, Experts Say

May 1, 2019

(CNN) – An experimental treatment for the rapidly progressive disease ALS, or amyotrophic lateral sclerosis, has been called potentially “game-changing.” The treatment, called tofersen, was found to slow the decline of muscular function associated with a genetic form of ALS in a study to be presented next weekat the annual meeting of the American Academy of Neurology.

Recommended Reading